Latest News about TEVA
Recent news which mentions TEVA
   Teva Pharmaceutical Lifts Revenue Forecast - Huntington's And Migraine Drugs Help Q3 Performance
   
  November 08, 2023
  Tickers 
   TEVA
  
  
  From Benzinga
 
   Teva shares climb as third-quarter sales top estimates
   
  
  
  November 08, 2023
  From MarketWatch
 
   US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings
   
  
  
  November 08, 2023
  From Benzinga
 
   Earnings Scheduled For November 8, 2023
   
  
  
  November 08, 2023
  From Benzinga
 
   Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook
   
  
  
  October 25, 2023
  From Benzinga
 From Benzinga
 
   Israel Could Form Emergency Government: Defense Stocks, Israel ETFs In Focus During Conflict
   
  
  
  October 10, 2023
  From Benzinga
 
   Israeli Stocks Fall as Investors Fear Middle East Conflict
   
  
  October 09, 2023
  Tags
   MBLY
   Today's Market
   NASDAQ:MBLY,NASDAQ:MNDY,NYSE:FVRR,NYSE:TEVA,NASDAQ:HUBC,NASDAQ:TATT,NASDAQ:ESLT
  
  From InvestorPlace
 
   Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
   
  
  
  October 09, 2023
  From Benzinga
 From MarketWatch
 
   Stock market is oversold — but investors don’t believe it yet
   
  
  
  October 05, 2023
  From MarketWatch
 From Benzinga
 
   Teva partnership with Sanofi ‘will pay dividends,’ analyst says
   
  
  
  October 04, 2023
  From MarketWatch
 
   Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People
   
  
  
  October 04, 2023
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  October 02, 2023
  From Benzinga
 
   Stocks are stuck in the breakdown lane and repairs will take time
   
  
  
  September 28, 2023
  From MarketWatch
 
   Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
   
  
  
  September 27, 2023
  From Benzinga
 
   Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
   
  
  
  September 27, 2023
  From Benzinga
 
   Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report
   
  
  
  September 26, 2023
  From Benzinga
 
   The bullish case for U.S. stocks is getting weaker
   
  
  
  September 21, 2023
  From MarketWatch
 
   Stocks are trapped in a trading range. Something’s got to give.
   
  
  
  September 14, 2023
  From MarketWatch
 
   3 No-Brainer Stocks to Buy With $20 Right Now
   
  
  
  September 13, 2023
  From Motley Fool
 
   Why Can't You Find Adderall? Inside the Ongoing Shortage of ADHD Medication In US
   
  September 12, 2023
  Tickers 
   TEVA
  
  
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  September 11, 2023
  From Benzinga
 
   How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
   
  
  
  September 11, 2023
  From Benzinga
 
   Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
   
  
  
  September 07, 2023
  From Benzinga
 From Benzinga
 
   Big Pharma Price-Fixing: Teva and Glenmark's $255M Settlement Shines Light on Industry Issues
   
  August 22, 2023
  Tickers 
   TEVA
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
